PT1370641E - Utilizacao de celulas estaminais e de celulas estaminais com deplecao de cd6 para inducao da tolerancia relativamente a transplantes alogenos e/ou para o tratamento da leucemia - Google Patents
Utilizacao de celulas estaminais e de celulas estaminais com deplecao de cd6 para inducao da tolerancia relativamente a transplantes alogenos e/ou para o tratamento da leucemiaInfo
- Publication number
- PT1370641E PT1370641E PT01986605T PT01986605T PT1370641E PT 1370641 E PT1370641 E PT 1370641E PT 01986605 T PT01986605 T PT 01986605T PT 01986605 T PT01986605 T PT 01986605T PT 1370641 E PT1370641 E PT 1370641E
- Authority
- PT
- Portugal
- Prior art keywords
- stem cells
- tolerance
- induction
- transplants
- alogene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10050334A DE10050334A1 (de) | 2000-10-11 | 2000-10-11 | Verwendung von Stammzellen und CD6-depletierten Stammzellen zur Toleranzinduktion gegenüber allogenen Transplantaten und/oder zur Leukämiebehandlung |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1370641E true PT1370641E (pt) | 2006-10-31 |
Family
ID=7659402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT01986605T PT1370641E (pt) | 2000-10-11 | 2001-10-11 | Utilizacao de celulas estaminais e de celulas estaminais com deplecao de cd6 para inducao da tolerancia relativamente a transplantes alogenos e/ou para o tratamento da leucemia |
Country Status (9)
Country | Link |
---|---|
US (1) | US8562968B2 (pt) |
EP (1) | EP1370641B1 (pt) |
JP (1) | JP4106488B2 (pt) |
AT (1) | ATE336568T1 (pt) |
DE (2) | DE10050334A1 (pt) |
DK (1) | DK1370641T3 (pt) |
ES (1) | ES2269486T3 (pt) |
PT (1) | PT1370641E (pt) |
WO (1) | WO2002030433A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2726879B1 (en) * | 2011-07-01 | 2022-10-19 | Beckman Coulter, Inc. | Requlatory t cells and methods of identifying and isolating them using cd6 -expression or the combination of cd4, cd25 and cd127 |
WO2019108584A1 (en) * | 2017-11-28 | 2019-06-06 | The Board Of Trustees Of The University Of Illinois | Multi-chimeric cell and therapy for transplantation and treatment of immune deficiencies and genetic disorders |
WO2020158924A1 (ja) * | 2019-01-31 | 2020-08-06 | 国立大学法人大阪大学 | 母児間免疫寛容を誘導する方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
US5772994A (en) * | 1993-05-28 | 1998-06-30 | The University Of Pittsburgh | Hematopoietic facilitatory cells and their uses |
US6217867B1 (en) * | 1993-09-13 | 2001-04-17 | University Of Pittsburgh | Non-lethal methods for conditioning a recipient for bone marrow transplantation |
US6447767B1 (en) * | 1997-05-23 | 2002-09-10 | Hadasit Medical Research Services And Development Ltd. | Non-myeloablative tolerogenic treatment |
EP1030675B1 (en) * | 1997-11-14 | 2009-08-12 | The General Hospital Corporation | Treatment of hematologic disorders |
CA2428721A1 (en) * | 2000-11-14 | 2002-05-23 | The General Hospital Corporation | Blockade of t cell migration into epithelial gvhd target tissues |
-
2000
- 2000-10-11 DE DE10050334A patent/DE10050334A1/de not_active Ceased
-
2001
- 2001-10-11 ES ES01986605T patent/ES2269486T3/es not_active Expired - Lifetime
- 2001-10-11 AT AT01986605T patent/ATE336568T1/de active
- 2001-10-11 JP JP2002533873A patent/JP4106488B2/ja not_active Expired - Fee Related
- 2001-10-11 DE DE50110773T patent/DE50110773D1/de not_active Expired - Lifetime
- 2001-10-11 DK DK01986605T patent/DK1370641T3/da active
- 2001-10-11 WO PCT/EP2001/011776 patent/WO2002030433A2/de active IP Right Grant
- 2001-10-11 PT PT01986605T patent/PT1370641E/pt unknown
- 2001-10-11 EP EP01986605A patent/EP1370641B1/de not_active Expired - Lifetime
-
2003
- 2003-04-10 US US10/410,852 patent/US8562968B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE336568T1 (de) | 2006-09-15 |
EP1370641A2 (de) | 2003-12-17 |
US20030232433A1 (en) | 2003-12-18 |
WO2002030433A2 (de) | 2002-04-18 |
JP2004510821A (ja) | 2004-04-08 |
WO2002030433A3 (de) | 2003-10-09 |
DE10050334A1 (de) | 2002-04-25 |
ES2269486T3 (es) | 2007-04-01 |
EP1370641B1 (de) | 2006-08-16 |
US8562968B2 (en) | 2013-10-22 |
JP4106488B2 (ja) | 2008-06-25 |
DE50110773D1 (de) | 2006-09-28 |
DK1370641T3 (da) | 2006-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02012271A (es) | Nuevos compuestos que poseen actividad antibacteriana, antifungal o antitumor. | |
BRPI0516795A (pt) | composto de 3-aminocarbonil biciclohepteno piramidinadiamina enriquecidos estereoisomericamente e seus usos | |
WO2005118544A3 (en) | Cycloalkyl substituted pyrimidinediamine compounds and their uses | |
BR0209129A (pt) | Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos | |
WO2002030358A3 (en) | Modulation of ccr4 function | |
BR0207172A (pt) | Pirido-pirimidinas 6-substituìdas | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
GB0111186D0 (en) | Novel compounds | |
HK1052940A1 (en) | Synthetic methods for aplidine and new antitumoralderivatives, methods of making and using them | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
WO2002101073A3 (en) | Aryl-benzimidazole compounds having antiinfective activity | |
BR0209128A (pt) | Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
WO2003045324A3 (en) | 14-methyl-epothilones | |
AP2001002274A0 (en) | Rescorcinol derivatives. | |
TW200519103A (en) | Pesticidal agents | |
PT1370641E (pt) | Utilizacao de celulas estaminais e de celulas estaminais com deplecao de cd6 para inducao da tolerancia relativamente a transplantes alogenos e/ou para o tratamento da leucemia | |
DE50114181D1 (de) | Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz | |
DE602004029924D1 (de) | Orale zusammensetzung mit einer ersten zusammensetzung (a) und einer zweiten zusammensetzung (b) zur verwendung als gemische zur getrennten oder aufeiandlung des menschlichen körpers | |
BR0116123A (pt) | Carbazóis antitumorais | |
ATE393624T1 (de) | Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs | |
BRPI0414701A (pt) | uso de um composto de vitamina d, método de prevenção ou tratamnento de disfunção de bexiga em um paciente, composto de vitamina d, e, kit | |
AU2001282238A1 (en) | Dihydroporphyrin derivatives and their uses | |
BR0316245A (pt) | Atividade antimicrobiana de espécie de oxigênio reativo produtora de anticorpos | |
DE60130009D1 (de) | Makrolide | |
WO2002061065A3 (en) | Phosphorylated glyoxalase i and its use |